Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron in Off-Pump Coronary Artery Bypass Surgery
NCT02139241Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ramosetron in hypotension (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Corrected QT interval. Started Jun 2013; status: completed.
02
Drugs
ramosetron
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT02139241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139241.